Shoulder Innovations

Shoulder Innovations Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Shoulder Innovations (SI) as of Oct 24, 2026 is 70.89 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 90.55 % — a change of -21.71% (lower).

Cash Conversion

70.89 %

YoY

-21.71%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Shoulder Innovations is 2025 70.89 % . Cash Conversion Rate (OCF/Net Income) of Shoulder Innovations was 2024 90.55 % . It decreases by -21.71% lower compared to the previous year.

The Shoulder Innovations Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
-13.77 USD
Jan 1, 2019
-511.53 USD
Jan 1, 2020
-1,843.50 USD
Jan 1, 2021
105.64 USD
Jan 1, 2022
215.16 USD
Jan 1, 2023
103.86 USD
Jan 1, 2024
90.55 USD
Jan 1, 2025
70.89 USD
The Shoulder Innovations Cash Conversion history
YEARCash ConversionYoY
70.89 %-21.71%
90.55 %-12.82%
103.86 %-51.73%
215.16 %+103.67%
105.64 %-105.73%
-1,843.50 %+260.39%
-511.53 %+3,615.69%
-13.77 %-94.23%
-238.55 %-145.43%
525.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shoulder Innovations Stock analysis

What does Shoulder Innovations do? Shoulder Innovations Inc generates revenue through its advanced implant systems for shoulder arthroplasty, specifically the aTSA and rTSA systems, which address patient and surgeon needs with customizable configurations for anatomic or reverse procedures. The company's ecosystem includes enabling technologies, instrument systems, specialized support, and surgeon-to-surgeon collaboration, enhancing preoperative planning, implant design, and procedural efficiency across the care chain. Its InSet Glenoid technology forms the foundational element of these systems, supporting comprehensive surgical solutions for healthcare providers. The firm targets hospitals and surgical centers as primary buyers, leveraging its commercial-stage medical technology focus to serve the shoulder surgical care market. The company's product portfolio centers on aTSA and rTSA systems, designed to improve core components of shoulder surgical care, with InSet Glenoid as the cornerstone of its implant solutions. These systems are sold to healthcare institutions seeking advanced surgical tools that streamline procedures and improve patient outcomes. Shoulder Innovations Inc capitalizes on its ecosystem approach, bundling implant systems with enabling technologies and support services to create a cohesive offering for medical professionals. The firm’s commercial-stage position allows it to directly engage with hospitals and surgical centers as key customers in the healthcare equipment and supplies sector. Shoulder Innovations Inc's revenue model relies on selling its advanced implant systems, including aTSA and rTSA, alongside InSet Glenoid technology, to hospitals and surgical centers. The company emphasizes procedural efficiency and preoperative planning through its ecosystem, which includes instrument systems and surgeon collaboration tools. By focusing on shoulder arthroplasty, the firm targets a specialized segment within the healthcare market, offering tailored solutions that address both patient requirements and surgical workflow optimization. The company’s products are designed to integrate seamlessly into existing surgical practices, enhancing care delivery across the shoulder surgical care chain. Shoulder Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shoulder Innovations stock

Cash Conversion Rate (OCF/Net Income) of Shoulder Innovations is 70.89 % in 2025.

Cash Conversion Rate (OCF/Net Income) of Shoulder Innovations changed from 90.55 % to 70.89 %, representing a -21.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Shoulder Innovations since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Shoulder Innovations with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Shoulder Innovations

All Key Metrics — Shoulder Innovations